Close Menu

WALNUT CREEK,Calif.--The US Department of Energy's Joint Genome Institute has purchased an additional 60 MegaBace 1000 high-throughput DNA sequencers from Amersham Pharmacia Biotech, Nycomed Amersham's life science business. This acquisition brings the number of MegaBace sequencers in operation at the institute to 86. Trevor Hawkins, the institute's director of sequencing, said, "Since our initial order was installed in June, we have been extremely impressed with the results and performance of MegaBace."

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Wired reports on a microbial analysis of sketches drawn by Leonardo DaVinci.

Russia says its candidate SARS-CoV-2 vaccine has a very high efficacy rate in an initial analysis of clinical trial data, according to the Financial Times.

A new survey explores coronavirus vaccine hesitancy among Black and Latino individuals, the Washington Post reports.

In Nucleic Acids Research this week: the Aging Atlas database, a database of human metagenome-related metadata, and more.

Sponsored by

Diverse components of the UC Davis campus have been mobilized to deploy HTP testing to provide a safe working environment and keep the pandemic under control.